Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Schorer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Thrombosis Research|February 15, 1997
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibodyA E Schorer
The American Journal of Medicine|January 1, 1991
Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patientsK V Watson, A E Schorer
Thrombosis Research|November 15, 1989
Interleukin 1 enhances arterial thrombogenicity in vitroA E Schorer, J G White
American Journal of Hematology|November 1, 1995
Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrumA E Schorer, J Singh, M L Basara
The American Journal of Physiology|January 1, 1990
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cellsP J Shultz, A E Schorer, L Raij
British Journal of Haematology|October 1, 1987
Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cellsA E Schorer, C F Moldow, M E Rick
British Journal of Haematology|March 1, 1989
Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregationA E Schorer, N W Wickham, K V Watson
Prostaglandins and Medicine|July 1, 1978
Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesisA E Schorer, J M Gerrard, J G White, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1988
Endothelial cell heterogeneity: antioxidant profiles determine vulnerability to oxidant injuryG M Vercellotti, M Dobson, A E Schorer, et al.
Thrombosis and Haemostasis|December 15, 1986
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanismA E Schorer, M E Kaplan, G H Rao, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Thrombosis Research|February 15, 1997
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibodyA E Schorer
The American Journal of Medicine|January 1, 1991
Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patientsK V Watson, A E Schorer
Thrombosis Research|November 15, 1989
Interleukin 1 enhances arterial thrombogenicity in vitroA E Schorer, J G White
American Journal of Hematology|November 1, 1995
Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrumA E Schorer, J Singh, M L Basara
The American Journal of Physiology|January 1, 1990
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cellsP J Shultz, A E Schorer, L Raij
British Journal of Haematology|October 1, 1987
Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cellsA E Schorer, C F Moldow, M E Rick
British Journal of Haematology|March 1, 1989
Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregationA E Schorer, N W Wickham, K V Watson
Prostaglandins and Medicine|July 1, 1978
Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesisA E Schorer, J M Gerrard, J G White, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1988
Endothelial cell heterogeneity: antioxidant profiles determine vulnerability to oxidant injuryG M Vercellotti, M Dobson, A E Schorer, et al.
Thrombosis and Haemostasis|December 15, 1986
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanismA E Schorer, M E Kaplan, G H Rao, et al.
Pageof 2